Desktop Site
|
25 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
74,339.44
+486.50
+0.66 %
Corporate Announcement
Security Code
500660
Company
GlaxoSmithKline Pharmaceuticals Ltd
Exchange Received Time
05/10/2017 12:40:45
Exchange Disseminated Time
05/10/2017 12:40:51
Time Taken
00:00:06
October 25, 2017 |
10/05/17 12:40
Pursuant to clause 33 of the Listing Obligations and Disclosure requirements (LODR), Regulations, 2015, this is to inform you that a meeting of the Board of Directors of our Company will be held on Wednesday, 25th October, 2017, inter-alia, to consider and approve Un-Audited Financial Results for the second quarter and half year ended 30th September, 2017.
Attachment
<< Back
Recently Viewed